CD82 and non-small cell lung carcinoma: There was no correlation between CD82 expression and the stage of the NSCLC patients (Figure S3D), and also based on the staining of whole sections of early and advanced stage NSCLC (data not shown), suggesting that once malignancy is established, CD82 expression is downregulated with a small and insignificant reduction with disease progression.